Robert W Herring Jr. MD
Esophagus Disease, Hepatology & Liver Transplantation, Inflammatory Bowel Disease
Assistant Professor, Medicine-Gastroenterology, University of Tennessee Health Science Center College of Medicine
Join to View Full Profile
330 Wallace Rd# SUITE103Nashville, TN 37211
Phone+1 615-832-5530
Fax+1 615-832-5713
Dr. Herring is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Gastroenterology, 1983 - 1985
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1980 - 1983
University of Tennessee Health Science Center College of MedicineClass of 1980
Certifications & Licensure
TN State Medical License 1986 - 2024
NC State Medical License 1982 - 1988
MD State Medical License 1983 - 1986
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- AOA Medical School Scholastic Society School of Medicine, University of Tennessee
- Phi Beta Kappa Birmingham-Southern College
- Valedictorian John Overton High School
Clinical Trials
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis Start of enrollment: 2014 Apr 01
- Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 142 citationsSafety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase I...Naim Alkhouri, Robert Herring, Heidi Kabler, Zeid Kayali, Tarek Hassanein
Journal of Hepatology. 2022-09-01 - 60 citationsVolixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II studyPhilip N. Newsome, Melissa Palmer, Bradley Freilich, Muhammad Y. Sheikh, Aasim Sheikh
Journal of Hepatology. 2020-08-01 - 256 citationsCilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled TrialKeyur Patel, Stephen A. Harrison, Magdy Elkhashab, James F. Trotter, Robert Herring
Hepatology. 2020-07-01
Research History
- Principal InvestigatorI have 30 years of clinical trial experience as principal investigator in the following disease states HCV, HBV, NASH, PBC, Encephalopathy, UC, Crohn's, Esophagitis, GU, DU, Gastritis, Reflux, Polyps, OA, RA, Psoriasis, Hypertension, Diarrhea, Constipation, and other internal medicine disease states1983 - 2014
Professional Memberships
- Fellow
- Member
- Member
- American Association for the Study of Disease - AASLDMember
- European Association for the Study of the Liver - EASLMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
